degarelix
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of adult men with advanced hormone-sensitive prostate cancer.
Form: powder for injection solution
Active substance Dosage degarelix 80 mg ATC: L02BX02
Manufacturer: Ferring GmbH (manufacturer of the finished product, responsible for primary packaging, quality control and batch release)
-
The drug is intended for the treatment of adult men with advanced hormone-sensitive prostate cancer.
Form: powder for injection solution
Active substance Dosage degarelix 120 mg ATC: L02BX02
Manufacturer: Ferring GmbH (manufacturer of the finished product, responsible for primary packaging, quality control and batch release)